{"protocolSection":{"identificationModule":{"nctId":"NCT04614948","orgStudyIdInfo":{"id":"CR108916"},"secondaryIdInfos":[{"id":"2020-003643-29","type":"EUDRACT_NUMBER"},{"id":"VAC31518COV3009","type":"OTHER","domain":"Janssen Vaccines & Prevention B.V."}],"organization":{"fullName":"Janssen Vaccines & Prevention B.V.","class":"INDUSTRY"},"briefTitle":"A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults","officialTitle":"A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older","acronym":"ENSEMBLE 2"},"statusModule":{"statusVerifiedDate":"2025-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":true,"nctId":"NCT04817657","statusForNctId":"NO_LONGER_AVAILABLE"},"startDateStruct":{"date":"2020-11-12","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-06-18","type":"ACTUAL"},"completionDateStruct":{"date":"2023-06-18","type":"ACTUAL"},"studyFirstSubmitDate":"2020-11-03","studyFirstSubmitQcDate":"2020-11-03","studyFirstPostDateStruct":{"date":"2020-11-04","type":"ACTUAL"},"resultsFirstSubmitDate":"2024-06-14","resultsFirstSubmitQcDate":"2024-09-13","resultsFirstPostDateStruct":{"date":"2024-10-09","type":"ACTUAL"},"lastUpdateSubmitDate":"2025-01-31","lastUpdatePostDateStruct":{"date":"2025-02-04","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Janssen Vaccines & Prevention B.V.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The study will evaluate the efficacy of Ad26.COV2.S in the prevention of molecularly confirmed moderate to severe/critical coronavirus disease-2019 (COVID-19), as compared to placebo, in SARS-CoV-2 seronegative adults in the double-blind phase and to describe COVID-19 outcomes, safety, and immunogenicity in the different study cohorts in open-label phase.","detailedDescription":"The aim of the COVID-19 vaccine clinical development program is to develop a safe and effective vaccine for the prevention of COVID-19. Ad26.COV2.S, a COVID-19 vaccine based on a human replication-incompetent Ad26 vector, constructed to encode the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus spike (S) protein, is being developed. The study will consist of: a screening phase (up to 28 days), study period (60-week), and a long-term follow-up period (1 additional year). The total study duration will be maximum 2 years and 3 months for the participants. Assessments for efficacy (COVID-19 signs and symptoms, etc.), immunogenicity (such as humoral immune responses), and safety (such as adverse events \\[AEs\\] monitoring) will be performed throughout the study."},"conditionsModule":{"conditions":["Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":31835,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Ad26.COV2.S","type":"EXPERIMENTAL","description":"Participants will receive intramuscular (IM) injection of Ad26.COV2.S vaccine on Day 1 and Day 57 in the double-blind phase. At unblinding visit (open-label phase), participants who have not yet received second vaccination will receive second dose of Ad26.COV2.S vaccine on Day 57, if applicable and newly enrolled participants will either receive IM injection of one dose of Ad26.COV2.S vaccine on Day 1 or two doses of Ad26.COV2.S vaccine on Day 1 and Day 57. All ongoing participants who only received a single vaccination with Ad26.COV2.S in the study will be offered to receive single booster dose of Ad26.COV2.S in the open label phase preferably within 6 to 12 months after the participant's first Ad26.COV2.S vaccination.","interventionNames":["Biological: Ad26.COV2.S"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","description":"Participants will receive IM injection of placebo on Day 1 and Day 57 in the double-blind phase. At unblinding visit (open-label phase), participants initially receiving placebo will be offered to receive IM injection of a single dose of Ad26.COV2.S vaccine. All ongoing participants who only received a single vaccination with Ad26.COV2.S in the study will be offered to receive single booster dose of Ad26.COV2.S in the open label phase preferably within 6 to 12 months after the participant's first Ad26.COV2.S vaccination.","interventionNames":["Biological: Ad26.COV2.S","Other: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"Ad26.COV2.S","description":"Ad26.COV2.S vaccine will be administered on Day 1 and Day 57 in the double-blind phase. At unblinding visit Ad26.COV2.S vaccine will be administered to participants at Day 57 who have not yet received second vaccination and in newly enrolled participants as either single dose on Day 1 or two doses on Day 1 and Day 57. Single dose of Ad26.COV2.S vaccine will also be administered to participants initially receiving placebo. Single booster dose of Ad26.COV2.S vaccine will be given to participants in the open label phase who have received only a single vaccination with Ad26.COV2.S.","armGroupLabels":["Ad26.COV2.S","Placebo"],"otherNames":["JNJ-78436735","Ad26COVS1","VAC31518"]},{"type":"OTHER","name":"Placebo","description":"Placebo will be administered as IM injection on Day 1 and Day 57.","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 in Seronegative Participants With Onset at Least 14 Days After the Second Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) positive reverse transcription/polymerase chain reaction (RT-PCR) or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>=20 breaths per minute (min) and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>=90 beats/min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/min, heart rate \\>=125 beats/min, oxygen saturation (SpO2) \\<=93 percent (%) on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to Intensive Care Unit (ICU), death defined as per FDA guidance.","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)"}],"secondaryOutcomes":[{"measure":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 Regardless of Serostatus With Onset At Least 1 Day After the First Day 1 Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate greater than or equal to (\\>=) 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 less than or equal to (\\<=) 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per US Food and Drug Administration (FDA) guidance.","timeFrame":"From at least 1 day after first vaccination on Day 1 (Day 2) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 Regardless of Serostatus With Onset at Least 14 Days After the Second Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 \\<= 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 in Seronegative Participants With Onset at Least 1 Day After the First Day 1 Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 \\<= 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","timeFrame":"From at least 1 day after first vaccination on Day 1 (Day 2) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 With Onset at Least 14 Days After the First Day 1 Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 \\<= 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","timeFrame":"From at least 14 days after first vaccination on Day 1 (Day 15) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 With Onset at Least 28 Days After the First Day 1 Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 \\<= 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","timeFrame":"From at least 28 days after the first vaccination on Day 1 (Day 29) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With First Occurrence of COVID-19 Requiring Medical Intervention With Onset at Least 14 Days After the Second Vaccination","description":"Number of participants with first occurrence of COVID-19 requiring medical intervention (such as a composite endpoint of hospitalization, ICU admission, mechanical ventilation, and extracorporeal membrane oxygenation \\[ECMO\\]), linked to objective measures such as decreased oxygenation, X-ray or computed tomography \\[CT\\] findings and linked to any molecularly confirmed, COVID-19 with onset at least 14 days post second vaccination were reported.","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Area Under the Curve (AUC) of SARS-CoV-2 Viral Load as Assessed by Quantitative RT-PCR in Participants With Molecularly Confirmed Symptomatic COVID-19 With Onset at Least 14 Days After Second Vaccination","description":"AUC of SARS-CoV-2 viral load was assessed in confirmed COVID-19 cases using RT-PCR. Nasal swabs were used to detect and/or quantify SARS-CoV-2. Due to change in the planned analysis, data was collected and analyzed for participants with molecularly confirmed symptomatic COVID-19 regardless of severity that is mild, moderate or severe and was not collected and analyzed separately for moderate to severe cases.","timeFrame":"From Day 71 up to end of the COVID-19 episode (up to 90 days)"},{"measure":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Mild COVID-19 With Onset at Least 14 Days After the Second Vaccination","description":"Molecularly confirmed mild Covid-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample and one of the following signs and symptoms: fever (\\>=38 degree Celsius or \\>=100.4 degree Fahrenheit), sore throat, malaise (loss of appetite, generally unwell, fatigue, physical weakness), headache, muscle pain (myalgia), gastrointestinal symptoms, cough, chest congestion, runny nose, wheezing, skin rash, eye irritation or discharge, chills, new or changing olfactory or taste disorders, red or bruised looking feet or toes, or shaking chills or rigors.","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed COVID-19 Defined by the US FDA Harmonized Case Definition With Onset at Least 14 Days After the Second Vaccination","description":"Molecularly confirmed COVID-19 was defined as SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample; and COVID-19 symptoms consistent with those defined by the US FDA harmonized case definition at the time of finalization of the study protocol: fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea.","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With Burden of Disease (BOD) Based on First Occurrence of Molecularly Confirmed Symptomatic COVID-19 With Onset at Least 14 Days After the Second Vaccination","description":"BOD is a weighted version of the mild, moderate, and severe/critical vaccine efficacies and was evaluated based on the first occurrence of molecularly confirmed COVID-19, including mild, moderate or severe/critical COVID-19 case.","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With Serologic Conversion Between Day 71 up to Unblinding Visit Using an Enzyme-linked Immunosorbent Assay (ELISA)","description":"Number of participants with serologic conversion between Day 71 up to unblinding visit using an ELISA were reported. Due to change in planned analysis, data was collected and analyzed between Day 71 up to unblinding visit instead of from baseline to unblinding visit.","timeFrame":"From Day 71 up to unblinding visit (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With Asymptomatic Infection Detected By Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) With Onset at Least 14 Days After the Second Vaccination","description":"Number of participants with asymptomatic infection detected by RT-PCR with onset at least 14 days after the second vaccination (Day 71) were reported.","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With First Occurrence of SARS-CoV-2 Infection (Serologically and/or Molecularly Confirmed) With Onset at Least 14 Days After the Second Vaccination","description":"Number of participants with first occurrence of SARS-CoV-2 infection (serologically and/or molecularly confirmed) with onset at least 14 days after the second vaccination (Day 71) were reported.","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With Serious Adverse Events (SAEs)","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. SAE was any untoward medical occurrence that at any dose may result in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, is a suspected transmission of any infectious agent via a medicinal product.","timeFrame":"From Day 1 up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With Adverse Events of Special Interest (AESIs)","description":"Number of participants with AESIs were reported. AESIs were significant AEs that were judged to be of special interest because of clinical importance, known or suspected class effects, or based on nonclinical signals. Thrombosis with Thrombocytopenia Syndrome (TTS), a syndrome characterized by a combination of both a thrombotic event and thrombocytopenia, was considered to be an AESI in this study. A suspected TTS case was defined as: Thrombotic events: suspected deep vessel venous or arterial thrombotic events; Thrombocytopenia, defined as platelet count below 150,000/micro liter.","timeFrame":"From Day 1 up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With Medically-Attended Adverse Events (MAAEs)","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. MAAEs were defined as AEs with medically-attended visits including hospital, emergency room, urgent care clinic, or other visits to or from medical personnel for any reason.","timeFrame":"From Day 1 up to 7.2 months"},{"measure":"Double-Blind: Number of Participants With MAAEs Leading to Study Discontinuation","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. MAAEs were defined as AEs with medically-attended visits including hospital, emergency room, urgent care clinic, or other visits to or from medical personnel for any reason.","timeFrame":"From Day 1 up to end of double blind phase (7.2 months)"},{"measure":"Double Blind Phase: Number of Participants With Solicited Local Adverse Events (AEs) During 7 Days Following Each Vaccination","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. Participants who were enrolled in safety subset (SS) were asked to note in the e-Diary occurrences of injection site pain/tenderness, erythema, and swelling at the study vaccine injection site daily for 7 days post each vaccination (day of vaccination and the subsequent 7 days).","timeFrame":"7 days after first vaccination on Day 1 (up to Day 8), 7 days after second vaccination on Day 57 (up to Day 64)"},{"measure":"Double Blind Phase: Number of Participants With Solicited Systemic AEs During 7 Days Following Each Vaccination","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. Participants who were enrolled in safety subset were instructed on how to record daily temperature using a thermometer provided for home use. Participants recorded temperature in e-Diary in evening of the day of vaccination, and then daily for next 7 days approximately at same time each day. If more than 1 measurement was made on any given day, the highest temperature of that day was recorded in e-Diary. Fever was defined as endogenous elevation of body temperature \\>= 38.0 degree Celsius or \\>=100.4-degree Fahrenheit, as recorded in at least 1 measurement. Participants also noted the signs and symptoms in e-Diary on a daily basis for 7 days post each vaccination (day of vaccination and subsequent 7 days), for the following events: fatigue, headache, nausea, myalgia.","timeFrame":"7 days after first vaccination on Day 1 (up to Day 8), 7 days after second vaccination on Day 57 (up to Day 64)"},{"measure":"Double Blind Phase: Number of Participants With Unsolicited Adverse Events (AEs) During 28 Days Post Each Vaccination","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. Unsolicited AEs were all AEs for which the participant is not specifically questioned in the participant diary.","timeFrame":"28 days after first vaccination on Day 1 (up to Day 29), 28 days after second vaccination on Day 57 (up to Day 85)"},{"measure":"Double Blind Phase: SARS-CoV-2 Binding Antibodies Assessed by ELISA","description":"Binding antibodies to SARS-CoV-2 S protein as assessed by ELISA to measure humoral immune response was reported. The lower limit of quantification (LLOQ) was 50.3 ELISA units per milliliter (EU/mL). A sample was considered positive if the value was strictly greater than the LLOQ (\\>LLOQ).","timeFrame":"At Baseline (Day 1), Days 29, 57 and 71"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Contraceptive (birth control) use should be consistent with local regulations regarding the acceptable methods of contraception for those participating in clinical studies\n* All participants of childbearing potential must: have a negative highly sensitive urine pregnancy test at screening; and have a negative highly sensitive urine pregnancy test immediately prior to each study vaccine administration\n* Participant agrees to not donate bone marrow, blood, and blood products from the first study vaccine administration until 3 months after receiving the last dose of study vaccine\n* Must be willing to provide verifiable identification, has means to be contacted and to contact the investigator during the study\n* Must be able to read, understand, and complete questionnaires in the electronic clinical outcome assessment (eCOA) (that is, the coronavirus disease-2019 \\[COVID 19\\] signs and symptoms surveillance question, the e-Diary, and the electronic patient-reported outcomes (ePROs)\n\nExclusion Criteria:\n\n* Participant has a clinically significant acute illness (this does not include minor illnesses such as diarrhea or mild upper respiratory tract infection) or temperature greater than or equal to (\\>=) 38.0 degree Celsius (100.4-degree Fahrenheit) within 24 hours prior to the planned first dose of study vaccine; randomization at a later date is permitted at the discretion of the investigator and after consultation with the sponsor\n* Participant has a known or suspected allergy or history of anaphylaxis or other serious adverse reactions to vaccines or their excipients\n* Participant received or plans to receive: (a) licensed live attenuated vaccines - within 28 days before or after planned administration of study vaccine; and (b) other licensed (not live) vaccines - within 14 days before or after planned administration of study vaccine\n* Participant previously received a coronavirus vaccine\n* Participant received an investigational drug within 30 days (including investigational drugs for prophylaxis of COVID-19) or used an invasive investigational medical device within 30 days or received investigational immunoglobulin (Ig) or investigational monoclonal antibodies within 3 months, or received convalescent serum for COVID-19 treatment within 4 months or received an investigational vaccine (including investigational Adenoviral-vectored vaccines) within 6 months before the planned administration of the first dose of study vaccine or is currently enrolled or plans to participate in another investigational study during the course of this study","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Janssen Vaccines & Prevention B.V. Clinical Trial","affiliation":"Janssen Vaccines & Prevention B.V.","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Achieve Clinical Research, LLC","city":"Vestavia Hills","state":"Alabama","zip":"35216","country":"United States","geoPoint":{"lat":33.44872,"lon":-86.78777}},{"facility":"Hope Research Institute","city":"Phoenix","state":"Arizona","zip":"85018","country":"United States","geoPoint":{"lat":33.44838,"lon":-112.07404}},{"facility":"Central Phoenix Medical Clinic","city":"Phoenix","state":"Arizona","zip":"85020","country":"United States","geoPoint":{"lat":33.44838,"lon":-112.07404}},{"facility":"Quality of Life Medical & Research Center, LLC","city":"Tucson","state":"Arizona","zip":"85712","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"Synexus Clinical Research US Inc","city":"Tucson","state":"Arizona","zip":"85712","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"Woodland International Research Group","city":"Little Rock","state":"Arkansas","zip":"72211","country":"United States","geoPoint":{"lat":34.74648,"lon":-92.28959}},{"facility":"Synexus Clinical Research US Inc","city":"Cerritos","state":"California","zip":"90703","country":"United States","geoPoint":{"lat":33.85835,"lon":-118.06479}},{"facility":"eStudySite","city":"Chula Vista","state":"California","zip":"91911","country":"United States","geoPoint":{"lat":32.64005,"lon":-117.0842}},{"facility":"Ark Clinical Research","city":"Long Beach","state":"California","zip":"90806","country":"United States","geoPoint":{"lat":33.76696,"lon":-118.18923}},{"facility":"Anthony Mills Medical, Inc","city":"Los Angeles","state":"California","zip":"90069","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"Benchmark Research","city":"Sacramento","state":"California","zip":"95684","country":"United States","geoPoint":{"lat":38.58157,"lon":-121.4944}},{"facility":"Artemis Institute for Clinical Research","city":"San Diego","state":"California","zip":"92103","country":"United States","geoPoint":{"lat":32.71571,"lon":-117.16472}},{"facility":"Paradigm Clinical Research Centers, Inc.","city":"Wheat Ridge","state":"Colorado","zip":"80033","country":"United States","geoPoint":{"lat":39.7661,"lon":-105.07721}},{"facility":"JEM Research LLC","city":"Atlantis","state":"Florida","zip":"33462","country":"United States","geoPoint":{"lat":26.5909,"lon":-80.10088}},{"facility":"Prestige Clinical Research Center, Inc.","city":"Coral Gables","state":"Florida","zip":"33134","country":"United States","geoPoint":{"lat":25.72149,"lon":-80.26838}},{"facility":"Avail Clinical Research, LLC","city":"DeLand","state":"Florida","zip":"32720","country":"United States","geoPoint":{"lat":29.02832,"lon":-81.30312}},{"facility":"Velocity Clinical Research, Hallandale Beach","city":"Hallandale","state":"Florida","zip":"33009","country":"United States","geoPoint":{"lat":25.9812,"lon":-80.14838}},{"facility":"Health Awareness inc.","city":"Jupiter","state":"Florida","zip":"33458","country":"United States","geoPoint":{"lat":26.93422,"lon":-80.09421}},{"facility":"Altus Research, Inc","city":"Lake Worth","state":"Florida","zip":"33461","country":"United States","geoPoint":{"lat":26.61708,"lon":-80.07231}},{"facility":"Compass Research, Melbourne","city":"Melbourne","state":"Florida","zip":"32940","country":"United States","geoPoint":{"lat":28.08363,"lon":-80.60811}},{"facility":"Suncoast Research Group","city":"Miami","state":"Florida","zip":"33135","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Behavioral Clinical Research , Inc","city":"North Miami","state":"Florida","zip":"33161","country":"United States","geoPoint":{"lat":25.89009,"lon":-80.18671}},{"facility":"Clinical NeuroScience Solutions Inc","city":"Orlando","state":"Florida","zip":"32806","country":"United States","geoPoint":{"lat":28.53834,"lon":-81.37924}},{"facility":"Progressive Medical Research","city":"Port Orange","state":"Florida","zip":"32127","country":"United States","geoPoint":{"lat":29.13832,"lon":-80.99561}},{"facility":"Meridien Research","city":"St. Petersburg","state":"Florida","zip":"33709","country":"United States","geoPoint":{"lat":27.77086,"lon":-82.67927}},{"facility":"Palm Beach Research Center","city":"West Palm Beach","state":"Florida","zip":"33409","country":"United States","geoPoint":{"lat":26.71534,"lon":-80.05337}},{"facility":"Atlanta Center for Medical Research","city":"Atlanta","state":"Georgia","zip":"30331","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Accel Research Sites","city":"Eatonton","state":"Georgia","zip":"31204","country":"United States","geoPoint":{"lat":33.3268,"lon":-83.3885}},{"facility":"The University Of Chicago Medicine","city":"Chicago","state":"Illinois","zip":"60637","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"Great Lakes Clinical Trials","city":"Chicago","state":"Illinois","zip":"60640","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"The South Bend Clinic Center for Research","city":"South Bend","state":"Indiana","zip":"46617-2808","country":"United States","geoPoint":{"lat":41.68338,"lon":-86.25001}},{"facility":"Heartland Research Associates, LLC","city":"Newton","state":"Kansas","zip":"67114","country":"United States","geoPoint":{"lat":38.04668,"lon":-97.34504}},{"facility":"University of Kentucky","city":"Lexington","state":"Kentucky","zip":"40536","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"Centex Studies, Inc.","city":"Lake Charles","state":"Louisiana","zip":"70601","country":"United States","geoPoint":{"lat":30.21309,"lon":-93.2044}},{"facility":"Ochsner Clinic Foundation","city":"New Orleans","state":"Louisiana","zip":"70121","country":"United States","geoPoint":{"lat":29.95465,"lon":-90.07507}},{"facility":"Centennial Medical Group","city":"Elkridge","state":"Maryland","zip":"21075","country":"United States","geoPoint":{"lat":39.21261,"lon":-76.71358}},{"facility":"Optimal Research","city":"Rockville","state":"Maryland","zip":"20850","country":"United States","geoPoint":{"lat":39.084,"lon":-77.15276}},{"facility":"Meridian Clinical Research, LLC","city":"Rockville","state":"Maryland","zip":"20854","country":"United States","geoPoint":{"lat":39.084,"lon":-77.15276}},{"facility":"Henry Ford Health Systems","city":"Detroit","state":"Michigan","zip":"48202","country":"United States","geoPoint":{"lat":42.33143,"lon":-83.04575}},{"facility":"Cherry Street Services, Inc.","city":"Grand Rapids","state":"Michigan","zip":"49503","country":"United States","geoPoint":{"lat":42.96336,"lon":-85.66809}},{"facility":"Washington University School Of Medicine","city":"St Louis","state":"Missouri","zip":"63110-1035","country":"United States","geoPoint":{"lat":38.62727,"lon":-90.19789}},{"facility":"Hassman Research Institute, LLC.","city":"Berlin","state":"New Jersey","zip":"08009","country":"United States","geoPoint":{"lat":39.79123,"lon":-74.92905}},{"facility":"Jersey Shore University Medical Center","city":"Neptune City","state":"New Jersey","zip":"07753","country":"United States","geoPoint":{"lat":40.20011,"lon":-74.02792}},{"facility":"Medpharmics, LLC","city":"Albuquerque","state":"New Mexico","zip":"87102","country":"United States","geoPoint":{"lat":35.08449,"lon":-106.65114}},{"facility":"Meridian Clinical Research, LLC","city":"Endwell","state":"New York","zip":"13760","country":"United States","geoPoint":{"lat":42.11285,"lon":-76.02103}},{"facility":"Regional Clinical Research, Inc.","city":"Endwell","state":"New York","zip":"13760","country":"United States","geoPoint":{"lat":42.11285,"lon":-76.02103}},{"facility":"Allergy Asthma Immunology of Rochester, PC (AAIR) - Research Center","city":"Rochester","state":"New York","zip":"14618","country":"United States","geoPoint":{"lat":43.15478,"lon":-77.61556}},{"facility":"Richmond Behavioral Associates","city":"Staten Island","state":"New York","zip":"10312","country":"United States","geoPoint":{"lat":40.56233,"lon":-74.13986}},{"facility":"American Health Network, LLC","city":"Charlotte","state":"North Carolina","zip":"28207","country":"United States","geoPoint":{"lat":35.22709,"lon":-80.84313}},{"facility":"Wilmington Health Associates","city":"Wilmington","state":"North Carolina","zip":"28401","country":"United States","geoPoint":{"lat":34.23556,"lon":-77.94604}},{"facility":"CTI Clinical Trial and Consulting Services","city":"Cincinnati","state":"Ohio","zip":"45212","country":"United States","geoPoint":{"lat":39.12711,"lon":-84.51439}},{"facility":"Lynn Health Science Institute","city":"Oklahoma City","state":"Oklahoma","zip":"73112","country":"United States","geoPoint":{"lat":35.46756,"lon":-97.51643}},{"facility":"Medical University of South Carolina","city":"Charleston","state":"South Carolina","zip":"29425","country":"United States","geoPoint":{"lat":32.77632,"lon":-79.93275}},{"facility":"Coastal Carolina Research Center","city":"Mt. Pleasant","state":"South Carolina","zip":"29464","country":"United States","geoPoint":{"lat":32.79407,"lon":-79.86259}},{"facility":"Centennial Medical Center","city":"Nashville","state":"Tennessee","zip":"37203","country":"United States","geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"Centex Studies, Inc.","city":"Houston","state":"Texas","zip":"77058","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Centex Studies, Inc.","city":"Houston","state":"Texas","zip":"77073","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Texas Center for Drug Development Inc","city":"Houston","state":"Texas","zip":"77081","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Centex Studies, Inc.","city":"McAllen","state":"Texas","zip":"78504","country":"United States","geoPoint":{"lat":26.20341,"lon":-98.23001}},{"facility":"Endeavor Clinical Trials, LLC","city":"San Antonio","state":"Texas","zip":"78229","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"Tranquility Clinical Research","city":"Webster","state":"Texas","zip":"77598","country":"United States","geoPoint":{"lat":29.53773,"lon":-95.11826}},{"facility":"JBR Clinical Research","city":"Salt Lake City","state":"Utah","zip":"84107","country":"United States","geoPoint":{"lat":40.76078,"lon":-111.89105}},{"facility":"Alliance for Multispeciality Research","city":"Norfolk","state":"Virginia","zip":"23502","country":"United States","geoPoint":{"lat":36.84681,"lon":-76.28522}},{"facility":"Anima","city":"Alken","zip":"3570","country":"Belgium","geoPoint":{"lat":50.87553,"lon":5.30558}},{"facility":"Institute of Tropical Medicine Antwerp","city":"Antwerp","zip":"2000","country":"Belgium","geoPoint":{"lat":51.22047,"lon":4.40026}},{"facility":"Center for Vaccinology (CEVAC)","city":"Ghent","zip":"9000","country":"Belgium","geoPoint":{"lat":51.05,"lon":3.71667}},{"facility":"UZ Leuven","city":"Leuven","zip":"3000","country":"Belgium","geoPoint":{"lat":50.87959,"lon":4.70093}},{"facility":"Az Sint-Maarten","city":"Mechelen","zip":"2800","country":"Belgium","geoPoint":{"lat":51.02574,"lon":4.47762}},{"facility":"Private Practice RESPISOM Namur","city":"Namur","zip":"5101","country":"Belgium","geoPoint":{"lat":50.4669,"lon":4.86746}},{"facility":"Hospital Nossa Senhora da Conceicao S A","city":"Porto Alegre","zip":"91350 200","country":"Brazil","geoPoint":{"lat":-30.03283,"lon":-51.23019}},{"facility":"Ministerio da Saude - Hospital dos Servidores do Estado - RJ","city":"Rio de Janeiro","zip":"20221-160","country":"Brazil","geoPoint":{"lat":-22.90642,"lon":-43.18223}},{"facility":"Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ","city":"Rio de Janeiro","zip":"21040-900","country":"Brazil","geoPoint":{"lat":-22.90642,"lon":-43.18223}},{"facility":"Instituto de infectologia Emilio Ribas","city":"São Paulo","zip":"01246-900","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Centro de Referencia E Treinamento Dst/Aids","city":"São Paulo","zip":"02141-000","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Fundacion Cardiomet CEQUIN","city":"Armenia","country":"Colombia","geoPoint":{"lat":4.53656,"lon":-75.67263}},{"facility":"IPS Centro Cientifico Asisitencial Jose Luis Accini S.A.S.","city":"Barranquilla","zip":"80020","country":"Colombia","geoPoint":{"lat":10.96854,"lon":-74.78132}},{"facility":"Asistencia Cientifica de Alta Complejidad S.A.S","city":"Bogotá","country":"Colombia","geoPoint":{"lat":4.60971,"lon":-74.08175}},{"facility":"Centro Medico Imbanaco de Cali S.A.","city":"Cali","zip":"760042","country":"Colombia","geoPoint":{"lat":3.43054,"lon":-76.5199}},{"facility":"T Y C Inversiones S A S Grupsalud","city":"Santa Marta","zip":"470001","country":"Colombia","geoPoint":{"lat":11.23855,"lon":-74.19427}},{"facility":"CHU de Montpellier Hopital Saint Eloi","city":"Montpellier","zip":"34295 cedex 05","country":"France","geoPoint":{"lat":43.61093,"lon":3.87635}},{"facility":"Hopital Cochin","city":"Paris","zip":"75014","country":"France","geoPoint":{"lat":48.85341,"lon":2.3488}},{"facility":"Hopital Saint-Antoine","city":"Paris","zip":"75571","country":"France","geoPoint":{"lat":48.85341,"lon":2.3488}},{"facility":"Groupe Hospitalier Sud Hôpital Haut-Leveque Service d'hematologie","city":"Pessac","zip":"33604","country":"France","geoPoint":{"lat":44.80565,"lon":-0.6324}},{"facility":"CHU Saint Etienne Hopital Nord","city":"Saint-Etienne","zip":"42055","country":"France","geoPoint":{"lat":45.43389,"lon":4.39}},{"facility":"Hopital Rangueil","city":"Toulouse","zip":"31054","country":"France","geoPoint":{"lat":43.60426,"lon":1.44367}},{"facility":"Hopital Purpan","city":"Toulouse","zip":"31059","country":"France","geoPoint":{"lat":43.60426,"lon":1.44367}},{"facility":"Hôpital de Brabois Adultes","city":"Vandœuvre-lès-Nancy","zip":"54511","country":"France","geoPoint":{"lat":48.66115,"lon":6.17114}},{"facility":"Klinikum rechts der Isar der TU Munchen","city":"München","zip":"81675","country":"Germany","geoPoint":{"lat":51.60698,"lon":13.31243}},{"facility":"Riverside Medical Center","city":"Bacolod","zip":"6100","country":"Philippines","geoPoint":{"lat":8.11667,"lon":123.91667}},{"facility":"West Visayas State University Medical Center","city":"Iloilo City","zip":"5000","country":"Philippines","geoPoint":{"lat":10.69694,"lon":122.56444}},{"facility":"Tropical Disease Foundation","city":"Makati","zip":"1230","country":"Philippines","geoPoint":{"lat":16.412,"lon":121.1226}},{"facility":"Makati Medical Center","city":"Manila","zip":"1000","country":"Philippines","geoPoint":{"lat":14.6042,"lon":120.9822}},{"facility":"Medical Center Manila","city":"Manila","zip":"1000","country":"Philippines","geoPoint":{"lat":14.6042,"lon":120.9822}},{"facility":"TREAD Research Tygerberg Hospital","city":"Cape Town","zip":"7500","country":"South Africa","geoPoint":{"lat":-33.92584,"lon":18.42322}},{"facility":"Centre of Tuberculosis Research Innovation","city":"Cape Town","zip":"7700","country":"South Africa","geoPoint":{"lat":-33.92584,"lon":18.42322}},{"facility":"Worthwhile Clinical trials","city":"Johannesburg","zip":"1501","country":"South Africa","geoPoint":{"lat":-26.20227,"lon":28.04363}},{"facility":"Peermed Clinical Trial Centre","city":"Kempton Park","zip":"1619","country":"South Africa","geoPoint":{"lat":-26.10859,"lon":28.2377}},{"facility":"Dr AA Mahomed Medical Centre","city":"Moloto South","zip":"1022","country":"South Africa","geoPoint":{"lat":-25.46279,"lon":28.65041}},{"facility":"VX Pharma","city":"Pretoria","zip":"0002","country":"South Africa","geoPoint":{"lat":-25.74486,"lon":28.18783}},{"facility":"Dr J.M. Engelbrecht Trial Site","city":"Somerset West","zip":"7130","country":"South Africa","geoPoint":{"lat":-34.08401,"lon":18.82113}},{"facility":"Be Part Yoluntu Centre","city":"Western Cape","zip":"7626","country":"South Africa"},{"facility":"Hosp. Univ. Germans Trias I Pujol","city":"Badalona","zip":"08916","country":"Spain","geoPoint":{"lat":41.45004,"lon":2.24741}},{"facility":"Hosp. Quiron Barcelona","city":"Barcelona","zip":"08023","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hosp Clinic de Barcelona","city":"Barcelona","zip":"08063","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hosp Univ Vall D Hebron","city":"Barcelona","zip":"8035","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hosp. Univ. de La Princesa","city":"Madrid","zip":"28006","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Clinica Univ. de Navarra","city":"Madrid","zip":"28027","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Hosp. Univ. de La Paz","city":"Madrid","zip":"28046","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Hosp. Quiron Madrid Pozuelo","city":"Madrid","zip":"28223","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Clinica Univ. de Navarra","city":"Pamplona","zip":"31008","country":"Spain","geoPoint":{"lat":42.81687,"lon":-1.64323}},{"facility":"Queen Elizabeth Hospital","city":"Birmingham","zip":"B15 2GW","country":"United Kingdom","geoPoint":{"lat":52.48142,"lon":-1.89983}},{"facility":"Powys Teaching Local Health Board - Bronllys Hospital","city":"Brecon","zip":"LD3 0UL","country":"United Kingdom","geoPoint":{"lat":51.94612,"lon":-3.38887}},{"facility":"Brighton & Sussex University Hospitals NHS Trust","city":"Brighton","zip":"BN2 5BE","country":"United Kingdom","geoPoint":{"lat":50.82838,"lon":-0.13947}},{"facility":"University Hospitals Bristol NHS Trust","city":"Bristol","zip":"BS2 8HW","country":"United Kingdom","geoPoint":{"lat":51.45523,"lon":-2.59665}},{"facility":"Cambridge University Hospitals NHS Foundation Trust","city":"Cambridge","zip":"CB2 0QQ","country":"United Kingdom","geoPoint":{"lat":52.2,"lon":0.11667}},{"facility":"Ninewells Hospital","city":"Dundee","zip":"DD1 9SY","country":"United Kingdom","geoPoint":{"lat":56.46913,"lon":-2.97489}},{"facility":"Royal Free Hospital","city":"Hampstead","zip":"NW3 2QG","country":"United Kingdom","geoPoint":{"lat":51.55744,"lon":-0.18213}},{"facility":"Leicester Royal Infirmary","city":"Leicester","country":"United Kingdom","geoPoint":{"lat":52.6386,"lon":-1.13169}},{"facility":"Guy's and St Thomas' Hospital","city":"London","zip":"SE1 9RT","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"Imperial College London and Imperial College Healthcare NHS Trust","city":"London","zip":"W2 1NY","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"Central Manchester University Hospitals NHS Foundation Trust","city":"Manchester","zip":"M13 9WL","country":"United Kingdom","geoPoint":{"lat":53.48095,"lon":-2.23743}},{"facility":"Newcastle upon Tyne Hospitals NHS Foundation Trust","city":"Newcastle upon Tyne","zip":"NE1 4LP","country":"United Kingdom","geoPoint":{"lat":54.97328,"lon":-1.61396}},{"facility":"University of Oxford","city":"Oxford","zip":"OX3 7JX","country":"United Kingdom","geoPoint":{"lat":51.75222,"lon":-1.25596}},{"facility":"Derriford Hospital","city":"Plymouth","zip":"PL6 8DH","country":"United Kingdom","geoPoint":{"lat":50.37153,"lon":-4.14305}},{"facility":"Sheffield Teaching Hospitals NHS Foundation Trust","city":"Sheffield","zip":"S10 2SB","country":"United Kingdom","geoPoint":{"lat":53.38297,"lon":-1.4659}},{"facility":"Southampton General Hospital","city":"Southampton","zip":"SO16 6YD","country":"United Kingdom","geoPoint":{"lat":50.90395,"lon":-1.40428}}]},"referencesModule":{"references":[{"pmid":"36113538","type":"DERIVED","citation":"Hardt K, Vandebosch A, Sadoff J, Le Gars M, Truyers C, Lowson D, Van Dromme I, Vingerhoets J, Kamphuis T, Scheper G, Ruiz-Guinazu J, Faust SN, Spinner CD, Schuitemaker H, Van Hoof J, Douoguih M, Struyf F; ENSEMBLE2 study group. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2022 Dec;22(12):1703-1715. doi: 10.1016/S1473-3099(22)00506-0. Epub 2022 Sep 13."}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"The data sharing policy of the Janssen Pharmaceutical Companies of Johnson \\& Johnson is available at www.janssen.com/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu","url":"https://www.janssen.com/clinical-trials/transparency"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"Due to change in the planned analysis, combined data of \"double blind (DB)\" and \"open label (OL)\" phase was collected and analyzed after completion of the double-blind phase. Results of safety outcome measures (OMs) were also collected and analyzed for combined DB and OL phase. Hence, safety data is reported only in adverse event section and not repeated in the OMs section.","recruitmentDetails":"Total of 31835 participants were randomized, out of which 130 participants were randomized but not vaccinated. Hence, 31705 participants received vaccination in both double blind (DB) and open label (OL) phase. After completion of DB phases more participants were enrolled therefore, the started count of DB+OL phase is exceeding the started count for DB phase.","groups":[{"id":"FG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"FG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."},{"id":"FG002","title":"Combined Double-blind and Open-label Phase: All Participants","description":"Each participant was initially randomized to receive 1 dose of 0.5 mL Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and on Day 57 or 1 dose of placebo vaccine intramuscularly on Day 1 and on Day 57 during the DB phase (up to 7.2 months). Following authorization of COVID-19 vaccine(s) in their country, participants could request to be unblinded to receive a different authorized/licensed COVID-19 vaccine outside of the study at any time during the study. Following Emergency Use Authorization of Ad26.COV2.S in the United States, all participants were unblinded and entered OL phase, and those participants that received placebo could receive a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine. Later it was allowed to have a booster vaccination with a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine for those participants that received a single dose of Ad26.COV2.S vaccine in the study."}],"periods":[{"title":"DB Phase (Day 1 up to 7.2 Months)","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"15708"},{"groupId":"FG001","numSubjects":"15592"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"FAS Post-Dose 1 Population","comment":"7 participants (3 in the Ad26 group, 4 in the placebo group) received a COVID-19 vaccination outside of the study prior to first study vaccination. These participants were excluded from post-dose 1 FAS.","achievements":[{"groupId":"FG000","numSubjects":"15705"},{"groupId":"FG001","numSubjects":"15588"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Non-FAS Post-Dose 1 Population","comment":"Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination.","achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"FAS Post-Dose 1 Safety Subset (Subset of FAS)","achievements":[{"groupId":"FG000","numSubjects":"3015"},{"groupId":"FG001","numSubjects":"3052"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Non-FAS Post-Dose 1 Safety Subset (Subset of FAS)","achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"15007"},{"groupId":"FG001","numSubjects":"13834"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"701"},{"groupId":"FG001","numSubjects":"1758"},{"groupId":"FG002","numSubjects":"0"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"10"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"13"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"170"},{"groupId":"FG001","numSubjects":"219"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"15"},{"groupId":"FG001","numSubjects":"6"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Pregnancy","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"7"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"468"},{"groupId":"FG001","numSubjects":"1273"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Initiated Prohibited Medication","reasons":[{"groupId":"FG000","numSubjects":"10"},{"groupId":"FG001","numSubjects":"75"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Rolled Over into Different Clinical Trial","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Technical Problems","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Other","reasons":[{"groupId":"FG000","numSubjects":"26"},{"groupId":"FG001","numSubjects":"149"},{"groupId":"FG002","numSubjects":"0"}]}]},{"title":"DB + Open-label Phase (2 Years 6 Months)","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","comment":"Participants of DB phase that entered into the OL phase. After completion of DB phases more participants were enrolled therefore, the started count of DB+OL phase is exceeding the started count for DB phase.","numSubjects":"31705"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"21018"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"10687"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"14"}]},{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"131"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"3796"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"178"}]},{"type":"Pregnancy","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"2"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"9"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"5922"}]},{"type":"Initiated Prohibited Medication","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"92"}]},{"type":"Rolled Over into Different Clinical Trial","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"48"}]},{"type":"Technical Problems","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"17"}]},{"type":"Sponsor Decision","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"}]},{"type":"Other","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"477"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"All Participants arm included combined baseline data for DB and OL phase as per change in the planned analysis.","groups":[{"id":"BG000","title":"Combined Double-blind and Open-label Phase: All Participants","description":"Each participant was initially randomized to receive 1 dose of 0.5 mL Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and on Day 57 or 1 dose of placebo vaccine intramuscularly on Day 1 and on Day 57 during the DB phase (up to 7.2 months). Following authorization of COVID-19 vaccine(s) in their country, participants could request to be unblinded to receive a different authorized/licensed COVID-19 vaccine outside of the study at any time during the study. Following Emergency Use Authorization of Ad26.COV2.S in the United States, all participants were unblinded and entered OL phase, and those participants that received placebo could receive a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine. Later it was allowed to have a booster vaccination with a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine for those participants that received a single dose of Ad26.COV2.S vaccine in the study."}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"31705"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"51.5","spread":"14.46"}]}]}]},{"title":"Age, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"From 18 to 64 years","measurements":[{"groupId":"BG000","value":"25993"}]},{"title":"From 65 to 84 years","measurements":[{"groupId":"BG000","value":"5640"}]},{"title":"85 years and over","measurements":[{"groupId":"BG000","value":"72"}]}]}]},{"title":"Sex/Gender, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"15032"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"16669"}]},{"title":"Undifferentiated","measurements":[{"groupId":"BG000","value":"4"}]}]}]},{"title":"Race/Ethnicity, Customized","description":"Race","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"798"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"2806"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"2677"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"78"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"24074"}]},{"title":"More Than One Race","measurements":[{"groupId":"BG000","value":"460"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"812"}]}]}]},{"title":"Race/Ethnicity, Customized","description":"Ethnicity","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"5799"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"25011"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"895"}]}]}]},{"title":"Region of Enrollment","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"BELGIUM","categories":[{"measurements":[{"groupId":"BG000","value":"2981"}]}]},{"title":"BRAZIL","categories":[{"measurements":[{"groupId":"BG000","value":"500"}]}]},{"title":"COLOMBIA","categories":[{"measurements":[{"groupId":"BG000","value":"2149"}]}]},{"title":"FRANCE","categories":[{"measurements":[{"groupId":"BG000","value":"714"}]}]},{"title":"GERMANY","categories":[{"measurements":[{"groupId":"BG000","value":"100"}]}]},{"title":"PHILIPPINES","categories":[{"measurements":[{"groupId":"BG000","value":"1572"}]}]},{"title":"SOUTH AFRICA","categories":[{"measurements":[{"groupId":"BG000","value":"2073"}]}]},{"title":"SPAIN","categories":[{"measurements":[{"groupId":"BG000","value":"3132"}]}]},{"title":"UNITED KINGDOM","categories":[{"measurements":[{"groupId":"BG000","value":"5905"}]}]},{"title":"UNITED STATES","categories":[{"measurements":[{"groupId":"BG000","value":"12579"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 in Seronegative Participants With Onset at Least 14 Days After the Second Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) positive reverse transcription/polymerase chain reaction (RT-PCR) or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>=20 breaths per minute (min) and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>=90 beats/min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/min, heart rate \\>=125 beats/min, oxygen saturation (SpO2) \\<=93 percent (%) on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to Intensive Care Unit (ICU), death defined as per FDA guidance.","populationDescription":"Per-protocol efficacy (PP) set: participants in FAS who received 2 doses of DB study vaccine, were PCR negative at time of first vaccination, were seronegative at time of first vaccination and at 14 days after second vaccination and had no other major protocol deviations to possibly impact efficacy of vaccine before unblinding. Participants who had a positive PCR test between Day 1 and Day 70 and participants who discontinued prior to 14 days post-dose 2 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6024"},{"groupId":"OG001","value":"5615"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"52"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 Regardless of Serostatus With Onset At Least 1 Day After the First Day 1 Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate greater than or equal to (\\>=) 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 less than or equal to (\\<=) 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per US Food and Drug Administration (FDA) guidance.","populationDescription":"Full analysis set (FAS) included all randomized participants with at least 1 documented study vaccine administration, regardless of protocol deviations and serostatus at enrollment.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 1 day after first vaccination on Day 1 (Day 2) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"15708"},{"groupId":"OG001","value":"15592"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"115"},{"groupId":"OG001","value":"259"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 Regardless of Serostatus With Onset at Least 14 Days After the Second Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 \\<= 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","populationDescription":"PP set: included participants of the FAS who received 2 doses of DB study vaccine, regardless of their serostatus at time of first vaccination and at 14 days after second vaccination, were PCR negative at time of first vaccination and had no other major protocol deviations to possibly impact efficacy of vaccine before unblinding. Participants who had a positive PCR test between Day 1 and Day 70 and participants who discontinued prior to 14 days post-dose 2 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6813"},{"groupId":"OG001","value":"6370"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"53"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 in Seronegative Participants With Onset at Least 1 Day After the First Day 1 Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 \\<= 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","populationDescription":"Full analysis seronegative set included all randomized participants with at least 1 documented study vaccine administration, regardless of protocol deviations and who were seronegative at baseline.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 1 day after first vaccination on Day 1 (Day 2) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"13951"},{"groupId":"OG001","value":"13871"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"256"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 With Onset at Least 14 Days After the First Day 1 Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 \\<= 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","populationDescription":"Per-protocol first dose efficacy (PPFD) population: Participants in FAS who received at least first dose of study vaccine in the double-blind phase and who were PCR negative at the time of first vaccination, who were not seropositive at baseline and who had no major protocol deviations before unblinding that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Days 1 and 14 and participants who discontinued prior to Day 15 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 14 days after first vaccination on Day 1 (Day 15) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"13316"},{"groupId":"OG001","value":"13286"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"216"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 With Onset at Least 28 Days After the First Day 1 Vaccination","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per min and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 \\<= 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","populationDescription":"PPFD population: Participants in FAS who received at least first dose of study vaccine in the double-blind phase and who were PCR negative at the time of first vaccination, who were not seropositive at baseline and who had no major protocol deviations before unblinding that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 28 and participants who discontinued prior to Day 29 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 28 days after the first vaccination on Day 1 (Day 29) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12632"},{"groupId":"OG001","value":"12402"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"161"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With First Occurrence of COVID-19 Requiring Medical Intervention With Onset at Least 14 Days After the Second Vaccination","description":"Number of participants with first occurrence of COVID-19 requiring medical intervention (such as a composite endpoint of hospitalization, ICU admission, mechanical ventilation, and extracorporeal membrane oxygenation \\[ECMO\\]), linked to objective measures such as decreased oxygenation, X-ray or computed tomography \\[CT\\] findings and linked to any molecularly confirmed, COVID-19 with onset at least 14 days post second vaccination were reported.","populationDescription":"PP set: participants in FAS who received 2 doses of DB study vaccine, were PCR negative at time of first vaccination, were seronegative at time of first vaccination and at 14 days after second vaccination and had no other major protocol deviations to possibly impact efficacy of vaccine before unblinding. Participants who had a positive PCR test between Day 1 and Day 70 and participants who discontinued prior to 14 days post-dose 2 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6024"},{"groupId":"OG001","value":"5615"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"5"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Area Under the Curve (AUC) of SARS-CoV-2 Viral Load as Assessed by Quantitative RT-PCR in Participants With Molecularly Confirmed Symptomatic COVID-19 With Onset at Least 14 Days After Second Vaccination","description":"AUC of SARS-CoV-2 viral load was assessed in confirmed COVID-19 cases using RT-PCR. Nasal swabs were used to detect and/or quantify SARS-CoV-2. Due to change in the planned analysis, data was collected and analyzed for participants with molecularly confirmed symptomatic COVID-19 regardless of severity that is mild, moderate or severe and was not collected and analyzed separately for moderate to severe cases.","populationDescription":"PP set: participants in FAS who received 2 doses of double-blind study vaccine, were PCR negative at the time of first vaccination, were seronegative at the time of first vaccination and at 14 days after second vaccination and had no other major protocol deviations to possibly impact efficacy of vaccine before unblinding. 'N' (overall number of participants analyzed) = participants evaluable for this outcome measure.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Error","unitOfMeasure":"Log10 copies*day per milliliter","timeFrame":"From Day 71 up to end of the COVID-19 episode (up to 90 days)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"47"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"847.68","spread":"242.375"},{"groupId":"OG001","value":"1023.59","spread":"156.298"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed Mild COVID-19 With Onset at Least 14 Days After the Second Vaccination","description":"Molecularly confirmed mild Covid-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample and one of the following signs and symptoms: fever (\\>=38 degree Celsius or \\>=100.4 degree Fahrenheit), sore throat, malaise (loss of appetite, generally unwell, fatigue, physical weakness), headache, muscle pain (myalgia), gastrointestinal symptoms, cough, chest congestion, runny nose, wheezing, skin rash, eye irritation or discharge, chills, new or changing olfactory or taste disorders, red or bruised looking feet or toes, or shaking chills or rigors.","populationDescription":"PP set: participants in FAS who received 2 doses of DB study vaccine, were PCR negative at time of first vaccination, were seronegative at time of first vaccination and at 14 days after second vaccination and had no other major protocol deviations to possibly impact efficacy of vaccine before unblinding. Participants who had a positive PCR test between Day 1 and Day 70 and participants who discontinued prior to 14 days post-dose 2 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6024"},{"groupId":"OG001","value":"5615"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed COVID-19 Defined by the US FDA Harmonized Case Definition With Onset at Least 14 Days After the Second Vaccination","description":"Molecularly confirmed COVID-19 was defined as SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample; and COVID-19 symptoms consistent with those defined by the US FDA harmonized case definition at the time of finalization of the study protocol: fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea.","populationDescription":"PP set: participants in FAS who received 2 doses of DB study vaccine, were PCR negative at time of first vaccination, were seronegative at time of first vaccination and at 14 days after second vaccination and had no other major protocol deviations to possibly impact efficacy of vaccine before unblinding. Participants who had a positive PCR test between Day 1 and Day 70 and participants who discontinued prior to 14 days post-dose 2 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6024"},{"groupId":"OG001","value":"5615"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"52"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With Burden of Disease (BOD) Based on First Occurrence of Molecularly Confirmed Symptomatic COVID-19 With Onset at Least 14 Days After the Second Vaccination","description":"BOD is a weighted version of the mild, moderate, and severe/critical vaccine efficacies and was evaluated based on the first occurrence of molecularly confirmed COVID-19, including mild, moderate or severe/critical COVID-19 case.","populationDescription":"PP set: participants in FAS who received 2 doses of DB study vaccine, were PCR negative at time of first vaccination, were seronegative at time of first vaccination and at 14 days after second vaccination and had no other major protocol deviations to possibly impact efficacy of vaccine before unblinding. Participants who had a positive PCR test between Day 1 and Day 70 and participants who discontinued prior to 14 days post-dose 2 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6024"},{"groupId":"OG001","value":"5615"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"53"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With Serologic Conversion Between Day 71 up to Unblinding Visit Using an Enzyme-linked Immunosorbent Assay (ELISA)","description":"Number of participants with serologic conversion between Day 71 up to unblinding visit using an ELISA were reported. Due to change in planned analysis, data was collected and analyzed between Day 71 up to unblinding visit instead of from baseline to unblinding visit.","populationDescription":"PP set: participants in FAS who received 2 doses of DB study vaccine, were PCR negative at time of first vaccination, were seronegative at time of first vaccination and at 14 days after second vaccination and had no other major protocol deviations to possibly impact efficacy of vaccine before unblinding. Participants who had a positive PCR test between Day 1 and Day 70 and participants who discontinued prior to 14 days post-dose 2 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 71 up to unblinding visit (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6024"},{"groupId":"OG001","value":"5615"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"45"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With Asymptomatic Infection Detected By Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) With Onset at Least 14 Days After the Second Vaccination","description":"Number of participants with asymptomatic infection detected by RT-PCR with onset at least 14 days after the second vaccination (Day 71) were reported.","populationDescription":"PP set: participants in FAS who received 2 doses of DB study vaccine, were PCR negative at time of first vaccination, were seronegative at time of first vaccination and at 14 days after second vaccination and had no other major protocol deviations to possibly impact efficacy of vaccine before unblinding. Participants who had a positive PCR test between Day 1 and Day 70 and participants who discontinued prior to 14 days post-dose 2 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6024"},{"groupId":"OG001","value":"5615"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"56"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With First Occurrence of SARS-CoV-2 Infection (Serologically and/or Molecularly Confirmed) With Onset at Least 14 Days After the Second Vaccination","description":"Number of participants with first occurrence of SARS-CoV-2 infection (serologically and/or molecularly confirmed) with onset at least 14 days after the second vaccination (Day 71) were reported.","populationDescription":"PP set: participants in FAS who received 2 doses of DB study vaccine, were PCR negative at time of first vaccination, were seronegative at time of first vaccination and at 14 days after second vaccination and had no other major protocol deviations to possibly impact efficacy of vaccine before unblinding. Participants who had a positive PCR test between Day 1 and Day 70 and participants who discontinued prior to 14 days post-dose 2 were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From at least 14 days after second vaccination on Day 57 (Day 71) up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6024"},{"groupId":"OG001","value":"5615"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"113"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With Serious Adverse Events (SAEs)","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. SAE was any untoward medical occurrence that at any dose may result in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, is a suspected transmission of any infectious agent via a medicinal product.","populationDescription":"FAS post dose 1 population included FAS participants excluding the participants who received a COVID-19 vaccination outside of the study prior to first study vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"15705"},{"groupId":"OG001","value":"15588"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"104"},{"groupId":"OG001","value":"136"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With Adverse Events of Special Interest (AESIs)","description":"Number of participants with AESIs were reported. AESIs were significant AEs that were judged to be of special interest because of clinical importance, known or suspected class effects, or based on nonclinical signals. Thrombosis with Thrombocytopenia Syndrome (TTS), a syndrome characterized by a combination of both a thrombotic event and thrombocytopenia, was considered to be an AESI in this study. A suspected TTS case was defined as: Thrombotic events: suspected deep vessel venous or arterial thrombotic events; Thrombocytopenia, defined as platelet count below 150,000/micro liter.","populationDescription":"FAS post dose 1 population included FAS participants excluding the participants who received a COVID-19 vaccination outside of the study prior to first study vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"15705"},{"groupId":"OG001","value":"15588"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With Medically-Attended Adverse Events (MAAEs)","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. MAAEs were defined as AEs with medically-attended visits including hospital, emergency room, urgent care clinic, or other visits to or from medical personnel for any reason.","populationDescription":"FAS post dose 1 population included FAS participants excluding the participants who received a COVID-19 vaccination outside of the study prior to first study vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 up to 7.2 months","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"15705"},{"groupId":"OG001","value":"15588"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1033"},{"groupId":"OG001","value":"1003"}]}]}]},{"type":"SECONDARY","title":"Double-Blind: Number of Participants With MAAEs Leading to Study Discontinuation","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. MAAEs were defined as AEs with medically-attended visits including hospital, emergency room, urgent care clinic, or other visits to or from medical personnel for any reason.","populationDescription":"FAS post dose 1 population included FAS participants excluding the participants who received a COVID-19 vaccination outside of the study prior to first study vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 up to end of double blind phase (7.2 months)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"15705"},{"groupId":"OG001","value":"15588"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"8"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With Solicited Local Adverse Events (AEs) During 7 Days Following Each Vaccination","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. Participants who were enrolled in safety subset (SS) were asked to note in the e-Diary occurrences of injection site pain/tenderness, erythema, and swelling at the study vaccine injection site daily for 7 days post each vaccination (day of vaccination and the subsequent 7 days).","populationDescription":"Safety population was a subset of FAS for analyzing solicited local AEs. 'N' (overall number of participants analyzed) = participants evaluable for this outcome; 'n' (number analyzed) = participants evaluable at specific time points. N=0 in 'DB: Non-FAS Post-Dose 1: Placebo' arm, as no participant was evaluable in the FAS subset of this arm. n=0 in 'DB: Non-FAS Post-Dose 1' arm signifies the time point was not applicable since the participant did not receive a second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"7 days after first vaccination on Day 1 (up to Day 8), 7 days after second vaccination on Day 57 (up to Day 64)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG002","title":"Double Blind Phase: Non-FAS Post-Dose 1: Ad26.COV2.S","description":"Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination were randomized to receive a single dose of 0.5 mL Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1."},{"id":"OG003","title":"Double Blind Phase: Non-FAS Post-Dose 1: Placebo","description":"Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination were randomized to receive a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3015"},{"groupId":"OG001","value":"3052"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"classes":[{"title":"Day 8","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3015"},{"groupId":"OG001","value":"3052"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1676"},{"groupId":"OG001","value":"653"},{"groupId":"OG002","value":"1"}]}]},{"title":"Day 64","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1559"},{"groupId":"OG001","value":"1425"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"252"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With Solicited Systemic AEs During 7 Days Following Each Vaccination","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. Participants who were enrolled in safety subset were instructed on how to record daily temperature using a thermometer provided for home use. Participants recorded temperature in e-Diary in evening of the day of vaccination, and then daily for next 7 days approximately at same time each day. If more than 1 measurement was made on any given day, the highest temperature of that day was recorded in e-Diary. Fever was defined as endogenous elevation of body temperature \\>= 38.0 degree Celsius or \\>=100.4-degree Fahrenheit, as recorded in at least 1 measurement. Participants also noted the signs and symptoms in e-Diary on a daily basis for 7 days post each vaccination (day of vaccination and subsequent 7 days), for the following events: fatigue, headache, nausea, myalgia.","populationDescription":"Safety population was subset of FAS for analysis of solicited systemic AEs. 'N' (overall number of participants analyzed)=participants evaluable for this outcome measure; 'n' (number analyzed)= participants evaluable at specified time points. N=0 in 'DB: Non-FAS Post-Dose 1: Placebo' arm, as no participant was evaluable in the FAS subset of this arm. n=0 in 'DB: Non-FAS Post-Dose 1' arm signifies the time point was not applicable since the participant did not receive a second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"7 days after first vaccination on Day 1 (up to Day 8), 7 days after second vaccination on Day 57 (up to Day 64)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG002","title":"Double Blind Phase: Non-FAS Post-Dose 1: Ad26.COV2.S","description":"Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination were randomized to receive a single dose of 0.5 mL Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1."},{"id":"OG003","title":"Double Blind Phase: Non-FAS Post-Dose 1: Placebo","description":"Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination were randomized to receive a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3015"},{"groupId":"OG001","value":"3052"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"classes":[{"title":"Day 8","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3015"},{"groupId":"OG001","value":"3052"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1764"},{"groupId":"OG001","value":"1138"},{"groupId":"OG002","value":"1"}]}]},{"title":"Day 64","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1559"},{"groupId":"OG001","value":"1425"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"821"},{"groupId":"OG001","value":"442"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: Number of Participants With Unsolicited Adverse Events (AEs) During 28 Days Post Each Vaccination","description":"An AE was any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product that does not necessarily have a causal relationship with the vaccine. Unsolicited AEs were all AEs for which the participant is not specifically questioned in the participant diary.","populationDescription":"Safety population was subset of FAS for analysis of unsolicited AEs. 'N' (overall number of participants analyzed) = participants evaluable for this outcome measure; 'n' (number analyzed) = participants evaluable at specified time points. N=0 in 'DB: Non-FAS Post-Dose 1: Placebo' arm, as no participant was evaluable in the FAS subset of this arm. n=0 in 'DB: Non-FAS Post-Dose 1' arm signifies the time point was not applicable since the participant did not receive a second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"28 days after first vaccination on Day 1 (up to Day 29), 28 days after second vaccination on Day 57 (up to Day 85)","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG002","title":"Double Blind Phase: Non-FAS Post-Dose 1: Ad26.COV2.S","description":"Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination were randomized to receive a single dose of 0.5 mL Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1."},{"id":"OG003","title":"Double Blind Phase: Non-FAS Post-Dose 1: Placebo","description":"Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination were randomized to receive a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3015"},{"groupId":"OG001","value":"3052"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"classes":[{"title":"Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3015"},{"groupId":"OG001","value":"3052"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"454"},{"groupId":"OG001","value":"332"},{"groupId":"OG002","value":"0"}]}]},{"title":"Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1559"},{"groupId":"OG001","value":"1425"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"159"},{"groupId":"OG001","value":"120"}]}]}]},{"type":"SECONDARY","title":"Double Blind Phase: SARS-CoV-2 Binding Antibodies Assessed by ELISA","description":"Binding antibodies to SARS-CoV-2 S protein as assessed by ELISA to measure humoral immune response was reported. The lower limit of quantification (LLOQ) was 50.3 ELISA units per milliliter (EU/mL). A sample was considered positive if the value was strictly greater than the LLOQ (\\>LLOQ).","populationDescription":"Per protocol immunogenicity (PPI) set: all randomized and vaccinated participants (received both vaccines in DB phase, including those who were part of immunogenicity subset and for whom immunogenicity data were available, excluding participants with major protocol deviations expected to impact immunogenicity outcomes. N (overall number of participants analyzed) = participants evaluated for this outcome measure, n (number analyzed) = number of participants evaluable at specified time points.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"ELISA Unit/milliliter (EU/mL)","timeFrame":"At Baseline (Day 1), Days 29, 57 and 71","groups":[{"id":"OG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57."},{"id":"OG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"157"},{"groupId":"OG001","value":"149"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"157"},{"groupId":"OG001","value":"149"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"NA","lowerLimit":"NA","upperLimit":"NA","comment":"Geometric mean and 95% confidence interval could not be estimated as the analyzed values were below the LLOQ (50.3 EU/mL)."},{"groupId":"OG001","value":"NA","lowerLimit":"NA","upperLimit":"NA","comment":"Geometric mean and 95% confidence interval could not be estimated as the analyzed values were below the LLOQ (50.3 EU/mL)."}]}]},{"title":"Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"140"},{"groupId":"OG001","value":"124"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"367","lowerLimit":"295","upperLimit":"456"},{"groupId":"OG001","value":"NA","lowerLimit":"NA","upperLimit":"NA","comment":"Geometric mean and 95% confidence interval could not be estimated as the analyzed values were below the LLOQ (50.3 EU/mL)."}]}]},{"title":"Day 57","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"150"},{"groupId":"OG001","value":"111"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"518","lowerLimit":"422","upperLimit":"635"},{"groupId":"OG001","value":"NA","lowerLimit":"NA","upperLimit":"NA","comment":"Geometric mean and 95% confidence interval could not be estimated as the analyzed values were below the LLOQ (50.3 EU/mL)."}]}]},{"title":"Day 71","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"78"},{"groupId":"OG001","value":"62"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2220","lowerLimit":"1794","upperLimit":"2748"},{"groupId":"OG001","value":"NA","lowerLimit":"NA","upperLimit":"NA","comment":"Geometric mean and 95% confidence interval could not be estimated as the analyzed values were below the LLOQ (50.3 EU/mL)."}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"2","timeFrame":"DB phase: All-cause mortality and SAEs: From Day 1 till end of DB phase (up to 7.2 months), Solicited AEs: 7 days after first vaccination on Day 1 (up to Day 8), 7 days after second vaccination on Day 57 (up to Day 64) ; All participants arm: All-cause mortality and SAEs: Day 1 up to end of study (up to 2 years 6 months); DB Phase: Other AEs: 28 days after first vaccination on Day 1 (up to Day 29 ), 28 days after vaccination 2 on Day 57 (up to Day 85)","description":"All-cause mortality/SAE: Per change in planned analysis, due to complex vaccination schedules, combined data for DB and OL was analyzed in the 'All Participant' arm after unblinding. As pre-specified: (a) only deaths/SAEs were planned to be collected in OL phase, (b) safety subset of FAS was used to analyze other AEs in DB phase. At risk=0 for 'All Participant' arm for other AEs as data for other AEs was not collected after unblinding (end of DB phase) per planned analysis. DB: MedDRA v24.0.","eventGroups":[{"id":"EG000","title":"Double Blind Phase: Ad26.COV2.S","description":"Participants received a single dose of 0.5 milliliter (mL) adenovirus type 26 vector coronavirus-2 spike protein (Ad26.COV2.S) 5\\*10\\^10 viral particles (vp) vaccine intramuscularly on Day 1 and Day 57.","deathsNumAffected":6,"deathsNumAtRisk":15705,"seriousNumAffected":104,"seriousNumAtRisk":15705,"otherNumAffected":2234,"otherNumAtRisk":3015},{"id":"EG001","title":"Double Blind Phase: Placebo","description":"Participants received a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and Day 57.","deathsNumAffected":13,"deathsNumAtRisk":15588,"seriousNumAffected":136,"seriousNumAtRisk":15588,"otherNumAffected":1531,"otherNumAtRisk":3052},{"id":"EG002","title":"Combined Double-blind and Open-label Phase: All Participants","description":"Each participant was initially randomized to receive 1 dose of 0.5 mL Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1 and on Day 57 or 1 dose of placebo vaccine intramuscularly on Day 1 and on Day 57 during the DB phase (up to 7.2 months). Following authorization of COVID-19 vaccine(s) in their country, participants could request to be unblinded to receive a different authorized/licensed COVID-19 vaccine outside of the study at any time during the study. Following Emergency Use Authorization of Ad26.COV2.S in the United States, all participants were unblinded and entered OL phase, and those participants that received placebo could receive a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine. Later it was allowed to have a booster vaccination with a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine for those participants that received a single dose of Ad26.COV2.S vaccine in the study.","deathsNumAffected":131,"deathsNumAtRisk":31705,"seriousNumAffected":1583,"seriousNumAtRisk":31705,"otherNumAffected":0,"otherNumAtRisk":0},{"id":"EG003","title":"Double Blind Phase: Non-FAS Post-Dose 1: Ad26.COV2.S","description":"Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination were randomized to receive a single dose of 0.5 mL Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1.","deathsNumAffected":0,"deathsNumAtRisk":3,"seriousNumAffected":0,"seriousNumAtRisk":3,"otherNumAffected":1,"otherNumAtRisk":1},{"id":"EG004","title":"Double Blind Phase: Non-FAS Post-Dose 1: Placebo","description":"Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination were randomized to receive a single dose of placebo matching to Ad26.COV2.S 5\\*10\\^10 vp vaccine intramuscularly on Day 1.","deathsNumAffected":0,"deathsNumAtRisk":4,"seriousNumAffected":0,"seriousNumAtRisk":4,"otherNumAffected":0,"otherNumAtRisk":0}],"seriousEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":10,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Anaemia megaloblastic","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Anaemia of chronic disease","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Febrile neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Immune thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Iron deficiency anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Leukopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lymphadenopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Myelosuppression","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Nephrogenic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pancytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Splenic vein thrombosis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":18,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Acute coronary syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":36,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":14,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Angina unstable","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":7,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aortic valve disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aortic valve incompetence","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aortic valve stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Arteriosclerosis coronary artery","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Arteriospasm coronary","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":2,"numAtRisk":15588},{"groupId":"EG002","numAffected":27,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Atrial flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Atrial tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Atrioventricular block","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Atrioventricular block complete","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Atrioventricular block first degree","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Atrioventricular block second degree","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bundle branch block left","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cardiac arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cardiac disorder","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":2,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cardiac failure acute","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":12,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cardio-respiratory arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cardiovascular disorder","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Congestive cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cor pulmonale","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":18,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Coronary artery occlusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Coronary artery stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":11,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Extrasystoles","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Heart valve incompetence","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ischaemic cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Microvascular coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Mitral valve disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Mitral valve incompetence","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Myocardial fibrosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":4,"numAtRisk":15588},{"groupId":"EG002","numAffected":24,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Myocardial ischaemia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Myocarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Palpitations","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pericardial effusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pericarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Sinus bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Sinus node dysfunction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Supraventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Tricuspid valve incompetence","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ventricular arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ventricular fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Brugada syndrome","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Congenital tracheomalacia","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypertrophic cardiomyopathy","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Laryngocele","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Phimosis","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Deafness neurosensory","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Adrenal insufficiency","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Autoimmune thyroiditis","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Basedow's disease","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Goitre","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypothyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Parathyroid disorder","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Thyroid cyst","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Thyroiditis acute","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Blindness transient","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cataract","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diplopia","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Epiretinal membrane","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Glaucoma","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Retinal detachment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Retinal ischaemia","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Scleritis","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Uveitis","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Vitreous detachment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abdominal adhesions","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abdominal distension","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abdominal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abdominal hernia obstructive","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":6,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abdominal pain lower","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abdominal wall haematoma","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Anal fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Appendicitis noninfective","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Colitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Colitis ischaemic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Colitis ulcerative","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Crohn's disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diaphragmatic hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diverticular perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diverticulum","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Duodenal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Duodenal ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Duodenal ulcer perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Duodenitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Enteritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Enterocele","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Enterocutaneous fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Epiploic appendagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Erosive oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Femoral hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastric haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastric ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastric ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastric ulcer perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastrointestinal ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":6,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Haematemesis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Haemorrhoidal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Haemorrhoids","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Haemorrhoids thrombosed","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hiatus hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ileus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":2,"numAtRisk":15588},{"groupId":"EG002","numAffected":16,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intestinal perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intestinal prolapse","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intestinal strangulation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intestinal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intra-abdominal haematoma","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Large intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Large intestine polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lower gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lumbar hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Mesenteric panniculitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Obstructive defaecation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oesophageal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oesophageal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oesophageal varices haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oral disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":7,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pancreatitis necrotising","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peptic ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peptic ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peritoneal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pharyngo-oesophageal diverticulum","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Rectal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Retroperitoneal mass","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Salivary gland mass","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Tongue haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Umbilical hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Upper gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":7,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Varices oesophageal","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Volvulus of small bowel","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Accidental death","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Capsular contracture associated with implant","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Chest discomfort","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":2,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Death","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":19,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Death neonatal","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gait disturbance","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hernia pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Injection site swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Multiple organ dysfunction syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Non-cardiac chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":6,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oedema peripheral","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Sudden death","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Vaccination site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Vascular stent stenosis","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bile duct stone","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Biliary cyst","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":10,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cholecystitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":15705},{"groupId":"EG001","numAffected":3,"numAtRisk":15588},{"groupId":"EG002","numAffected":19,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cirrhosis alcoholic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gallbladder disorder","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gallbladder polyp","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gallbladder rupture","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hepatic cirrhosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hepatic cyst","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hydrocholecystis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Jaundice","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Portal vein thrombosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Allergy to vaccine","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Anaphylactic reaction","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Food allergy","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abdominal wall abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abscess jaw","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abscess limb","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Anal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Appendiceal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":15705},{"groupId":"EG001","numAffected":4,"numAtRisk":15588},{"groupId":"EG002","numAffected":34,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Appendicitis perforated","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Arboviral infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Arthritis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aspergilloma","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bacterial sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bartholinitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bronchopulmonary aspergillosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Burn infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bursitis infective","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"COVID-19","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":15705},{"groupId":"EG001","numAffected":24,"numAtRisk":15588},{"groupId":"EG002","numAffected":78,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"COVID-19 pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":15705},{"groupId":"EG001","numAffected":13,"numAtRisk":15588},{"groupId":"EG002","numAffected":45,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Campylobacter gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Catheter site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":15,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cholecystitis infective","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Chronic hepatitis B","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Clostridium difficile colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Clostridium difficile infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Colonic abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Complicated appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cystitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cytomegalovirus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Dengue fever","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Device related infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diabetic foot infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Disseminated tuberculosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":7,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diverticulitis intestinal perforated","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Encephalitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Erysipelas","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Escherichia pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Escherichia urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Eye infection intraocular","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gangrene","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastric ulcer helicobacter","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastritis helminthic","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastroenteritis Escherichia coli","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastroenteritis norovirus","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"HIV infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Herpes zoster","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Infected bite","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Infectious mononucleosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Infective exacerbation of bronchiectasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intervertebral discitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Kidney infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Laryngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Localised infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lung abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lymphangitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Meningitis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Meningoencephalitis herpetic","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Murine typhus","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Neurosyphilis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ophthalmic herpes zoster","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Orchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Osteomyelitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pelvic inflammatory disease","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peritonitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Plasmodium falciparum infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumococcal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":45,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumonia aspiration","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumonia bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumonia pneumococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumonia pseudomonal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumonia staphylococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumonia viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Post procedural infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Post-acute COVID-19 syndrome","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pseudomonas infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pulmonary tuberculosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":6,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pyelonephritis acute","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":22,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Septic shock","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Shunt infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Sialoadenitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Spontaneous bacterial peritonitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Streptococcal bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Submandibular abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Suspected COVID-19","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Systemic candida","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Tonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Tubo-ovarian abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":2,"numAtRisk":15588},{"groupId":"EG002","numAffected":14,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urinary tract infection bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":10,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Vestibular neuronitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Viral infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Wound sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Acetabulum fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Alcohol poisoning","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Anaesthetic complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Anaphylactic transfusion reaction","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Animal bite","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ankle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Avulsion fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bone graft lysis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Brain contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Burns third degree","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Chest injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Clavicle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":6,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Craniocerebral injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Epicondylitis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Facial bones fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Femur fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":7,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Fibula fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Forearm fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Fractured sacrum","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Frostbite","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastrointestinal anastomotic leak","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gun shot wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hand fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Head injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":6,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Heat exhaustion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ilium fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intentional overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Joint dislocation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Joint injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ligament injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ligament rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ligament sprain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Limb injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lisfranc fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lower limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":2,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lumbar vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Meniscus injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Multiple fractures","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Multiple injuries","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Muscle rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Neck injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Osteoradionecrosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Patella fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pelvic fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Poisoning","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Post procedural complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Post procedural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Post-traumatic pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Procedural complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Procedural pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":7,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Procedural pneumothorax","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Radius fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":7,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Rib fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":12,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Road traffic accident","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Seroma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Skull fractured base","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Snake bite","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Spinal compression fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Spinal fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Subdural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Subdural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Synovial rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Tendon rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":9,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Tibia fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Traumatic arthrosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Traumatic intracranial haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ulna fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Upper limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urinary retention postoperative","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Wrist fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Biopsy liver","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cardiac murmur","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Electrocardiogram ST segment depression","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Heart rate irregular","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Myocardial necrosis marker increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Sleep study","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Troponin increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Adult failure to thrive","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diabetes mellitus inadequate control","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diabetic ketoacidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Electrolyte imbalance","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gout","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypercholesterolaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypervolaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":6,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":2,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Obesity","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Type 1 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Type 2 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Arthropathy","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Chondrolysis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Chondropathy","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Costochondritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diastasis recti abdominis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Foot deformity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":9,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Infrapatellar fat pad inflammation","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intervertebral disc degeneration","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intervertebral disc protrusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":16,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Jaw disorder","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Knee deformity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Limb discomfort","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lumbar spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Meniscopathy","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Muscle contracture","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Muscular weakness","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Myositis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Osteitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":2,"numAtRisk":15588},{"groupId":"EG002","numAffected":70,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Osteonecrosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Osteoporosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Periarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Rhabdomyolysis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Rotator cuff syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Scoliosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Spinal osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Spinal pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Spondylolisthesis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Synovitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Tendon disorder","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Vertebral lateral recess stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Acute leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Acute myeloid leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Adenocarcinoma gastric","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Adenocarcinoma of colon","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Adenocarcinoma pancreas","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Adrenal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Anal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Astrocytoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Basal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Benign neoplasm of testis","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bladder cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bladder transitional cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Borderline serous tumour of ovary","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Breast cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":22,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Breast cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Breast cancer recurrent","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Breast cancer stage I","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Breast cancer stage II","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Breast cancer stage IV","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bronchial carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cholangiocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cholesteatoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Chronic lymphocytic leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Clear cell renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Colon cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Colorectal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Endometrial cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Endometrial neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Fallopian tube cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Fibroma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Follicular lymphoma stage III","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Follicular thyroid cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gastrointestinal carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Glioblastoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Haemangioma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hepatocellular carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intraductal proliferative breast lesion","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Invasive ductal breast carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":7,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Invasive lobular breast carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Keratoacanthoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lipoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lung adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lung adenocarcinoma stage 0","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lung cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lung carcinoma cell type unspecified stage IV","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lung neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":6,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lung squamous cell carcinoma stage III","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Malignant melanoma stage I","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Malignant pleural effusion","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Meningioma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Metastases to bone","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Metastases to central nervous system","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Metastases to spine","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Metastatic malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Metastatic renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Nasopharyngeal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Neoplasm progression","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Neoplasm prostate","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Neuroendocrine carcinoma of the skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Non-Hodgkin's lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Non-small cell lung cancer stage IV","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oesophageal adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oesophageal adenocarcinoma stage III","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oesophageal carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oesophageal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Oesophageal squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Osteochondroma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Osteosarcoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ovarian cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Paget's disease of nipple","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Phyllodes tumour","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pituitary tumour benign","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Plasma cell myeloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":29,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Prostate cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Prostate cancer recurrent","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Prostate cancer stage I","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Prostatic adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Rectal adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Renal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Sarcoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Schwannoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Small cell lung cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Spinal cord neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Spinal meningioma benign","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Squamous cell carcinoma of lung","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Squamous cell carcinoma of pharynx","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Squamous cell carcinoma of skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Squamous cell carcinoma of the hypopharynx","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Squamous cell carcinoma of the tongue","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Squamous cell carcinoma of the vulva","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Testis cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Throat cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Transitional cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Tumour of ampulla of Vater","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Uterine leiomyoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aphasia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ataxia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bell's palsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Brain injury","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Brain oedema","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Carotid arteriosclerosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Carotid artery stenosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cauda equina syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cerebellar infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cerebellar stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cerebral amyloid angiopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cerebral thrombosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":12,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cervical radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cognitive disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diabetic ketoacidotic hyperglycaemic coma","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Dysarthria","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Facial paresis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Guillain-Barre syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Haemorrhagic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hashimoto's encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hemiparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hepatic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypoaesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypoglossal nerve paresis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypoxic-ischaemic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intracranial aneurysm","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intracranial mass","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ischaemic cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ischaemic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":12,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lacunar stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Loss of consciousness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lumbar radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Memory impairment","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Metabolic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Migraine","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Myelitis transverse","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Myelopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Neuralgia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Neuromyopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Normal pressure hydrocephalus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Nystagmus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Paresis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Partial seizures","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peroneal nerve palsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Post-traumatic epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Presyncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Primary headache associated with sexual activity","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pseudostroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"SUNCT syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Sciatica","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":8,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Spinal claudication","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Subarachnoid haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":11,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Tension headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Thalamic infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Transient global amnesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":14,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abortion","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abortion spontaneous","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":9,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ectopic pregnancy","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Foetal death","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gestational diabetes","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gestational hypertension","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"HELLP syndrome","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Placenta praevia","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Postpartum haemorrhage","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pre-eclampsia","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pregnancy","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Premature baby","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Premature separation of placenta","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Device dislocation","organSystem":"Product Issues","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Device failure","organSystem":"Product Issues","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Prosthetic cardiac valve malfunction","organSystem":"Product Issues","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Acute psychosis","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Affective disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Alcohol withdrawal syndrome","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Alcoholism","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bipolar I disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bipolar disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Completed suicide","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Conversion disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Delirium","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":10,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Depression suicidal","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Drug abuse","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Gender dysphoria","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intentional self-injury","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Nicotine dependence","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Post-traumatic stress disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Psychiatric decompensation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Schizoaffective disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Schizoaffective disorder bipolar type","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Schizophrenia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Substance-induced psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Suicidal ideation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":7,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Suicide attempt","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":10,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Calculus bladder","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Calculus urinary","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Chronic kidney disease","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"End stage renal disease","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hydronephrosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":3,"numAtRisk":15588},{"groupId":"EG002","numAffected":15,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Renal colic","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Renal cyst","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Renal impairment","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Renal mass","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Stress urinary incontinence","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urate nephropathy","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ureterolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urethral haemorrhage","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urethral obstruction","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urethral stenosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urinary bladder polyp","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urinary incontinence","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Urinary tract obstruction","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Abnormal uterine bleeding","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Adnexal torsion","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Benign prostatic hyperplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Breast discomfort","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Breast enlargement","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Breast mass","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cervical dysplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Colpocele","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cystocele","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Endometriosis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Erectile dysfunction","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Haemorrhagic ovarian cyst","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Heavy menstrual bleeding","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ovarian cyst","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":7,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ovarian disorder","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Ovarian hyperstimulation syndrome","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pelvic fluid collection","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Prostatitis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Rectocele","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Uterine prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Vaginal haemorrhage","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Vaginal prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Vulvar dysplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Acute respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":12,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Atelectasis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bronchitis chronic","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bronchospasm","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":10,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Chylothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Dyspnoea exertional","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Haemothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypersensitivity pneumonitis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Interstitial lung disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Lung disorder","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Mediastinal mass","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Nasal septum deviation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Neonatal dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Obstructive sleep apnoea syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Organising pneumonia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pharyngeal haematoma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pharyngeal swelling","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumomediastinum","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumonitis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pneumothorax spontaneous","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pulmonary congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":4,"numAtRisk":15588},{"groupId":"EG002","numAffected":35,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pulmonary hypertension","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Pulmonary mass","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Alopecia","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Diabetic foot","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Skin ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Stevens-Johnson syndrome","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Subcutaneous emphysema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Bereavement","organSystem":"Social circumstances","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Homicide","organSystem":"Social circumstances","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Miscarriage of partner","organSystem":"Social circumstances","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aneurysm thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aortic aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aortic aneurysm rupture","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aortic dilatation","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aortic stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Aortic thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Arteriosclerosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":4,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Circulatory collapse","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":9,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Essential hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":5,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypertensive crisis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypertensive urgency","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":3,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Hypovolaemic shock","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Iliac artery stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Intermittent claudication","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Malignant hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Microscopic polyangiitis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Penetrating aortic ulcer","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peripheral arterial occlusive disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peripheral artery aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peripheral artery occlusion","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peripheral artery stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peripheral artery thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peripheral embolism","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Peripheral venous disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Shock","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Superficial vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Systolic hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Varicose vein","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":1,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Venous thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Venous thrombosis limb","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":2,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":0,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Unevaluable event","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":15705},{"groupId":"EG001","numAffected":1,"numAtRisk":15588},{"groupId":"EG002","numAffected":0,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]},{"term":"Postoperative abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15705},{"groupId":"EG001","numAffected":0,"numAtRisk":15588},{"groupId":"EG002","numAffected":0,"numAtRisk":31705},{"groupId":"EG003","numAffected":0,"numAtRisk":3},{"groupId":"EG004","numAffected":0,"numAtRisk":4}]}],"otherEvents":[{"term":"Nausea(Solicited)","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"MedDRA version 24.0 was used for solicited non-SAEs.","stats":[{"groupId":"EG000","numAffected":666,"numAtRisk":3015},{"groupId":"EG001","numAffected":387,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Fatigue(Solicited)","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"MedDRA version 24.0 was used for solicited non-SAEs.","stats":[{"groupId":"EG000","numAffected":1531,"numAtRisk":3015},{"groupId":"EG001","numAffected":897,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Pyrexia(Solicited)","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"MedDRA version 24.0 was used for solicited non-SAEs.","stats":[{"groupId":"EG000","numAffected":177,"numAtRisk":3015},{"groupId":"EG001","numAffected":18,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Vaccination site erythema(Solicited)","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"MedDRA version 24.0 was used for solicited non-SAEs.","stats":[{"groupId":"EG000","numAffected":311,"numAtRisk":3015},{"groupId":"EG001","numAffected":170,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Vaccination site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":72,"numAtRisk":3015},{"groupId":"EG001","numAffected":23,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Vaccination site pain(Solicited)","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"MedDRA version 24.0 was used for solicited non-SAEs.","stats":[{"groupId":"EG000","numAffected":1818,"numAtRisk":3015},{"groupId":"EG001","numAffected":664,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Vaccination site swelling(Solicited)","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"MedDRA version 24.0 was used for solicited non-SAEs.","stats":[{"groupId":"EG000","numAffected":215,"numAtRisk":3015},{"groupId":"EG001","numAffected":65,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Myalgia(Solicited)","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"MedDRA version 24.0 was used for solicited non-SAEs.","stats":[{"groupId":"EG000","numAffected":1346,"numAtRisk":3015},{"groupId":"EG001","numAffected":572,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Headache(Solicited)","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"MedDRA version 24.0 was used for solicited non-SAEs.","stats":[{"groupId":"EG000","numAffected":1432,"numAtRisk":3015},{"groupId":"EG001","numAffected":873,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":128,"numAtRisk":3015},{"groupId":"EG001","numAffected":119,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":99,"numAtRisk":3015},{"groupId":"EG001","numAffected":86,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":138,"numAtRisk":3015},{"groupId":"EG001","numAffected":120,"numAtRisk":3052},{"groupId":"EG002","numAffected":0,"numAtRisk":0},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":0}]}]},"moreInfoModule":{"limitationsAndCaveats":{"description":"Per change in planned analysis, safety results for Open-label (OL) phase were included in the All Participants arm in AE section, hence are not repeated in OM section. There was no planned cross-over, the various complex vaccination sequences were a result of ethically allowing placebo participants to unblind themselves and receive active vaccination in OL phase. Hence data could not be analyzed separately for OL phase and was combined with DB phase after unblinding in 'All Participants' arm."},"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application."},"pointOfContact":{"title":"VICE PRESIDENT Medical Affairs IDV","organization":"Janssen Vaccines & Prevention B.V.","email":"ClinicalTrialDisclosure@its.jnj.com","phone":"844-434-4210"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2022-04-27","uploadDate":"2024-06-14T03:57","filename":"Prot_000.pdf","size":5545164},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2023-07-28","uploadDate":"2024-06-14T03:57","filename":"SAP_001.pdf","size":1510007}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09","submissionTracking":{"firstMcpInfo":{"postDateStruct":{"date":"2024-07-11","type":"ACTUAL"}}}},"interventionBrowseModule":{"meshes":[{"id":"D000090984","term":"Ad26COVS1"}],"ancestors":[{"id":"D000086663","term":"COVID-19 Vaccines"},{"id":"D014765","term":"Viral Vaccines"},{"id":"D014612","term":"Vaccines"},{"id":"D001688","term":"Biological Products"},{"id":"D045424","term":"Complex Mixtures"}]}},"hasResults":true}